癃闭舒胶囊治疗前列腺增生症的临床观察

• 作 者: 唐涌志 张元芳 张先有 张祖豹 钱松溪
• 机 构: 上海市静安区中心医院,上海医科大学华山医院,上海市第一人民医院,上海第二医科大学瑞金医院,第二军医大学长海医院
• 出 处: 上海中医药杂志
• 发表日期: 1999年02期
• 关键词: 癃闭舒胶囊 前列腺增生 临床观察 静安区中心医院 残余尿测定 残余尿量 流率 治疗法 通尿灵 泌尿科

上海市静安区中心医院等五家医院泌尿科对“癃闭舒胶囊”治疗中老年男性良性前列腺增生症的有效性和安全性进行临床验证，观察治疗１３８例结果：国际前列腺症状评分（ＩＰＳＳ）、残余尿测定与最大尿流率（ＭＦＲ）获显著改善的患者分别为８２例（共１３８例）、４６例（共１２９例）和３３例（共１３６例），改善率分别为５９４２％、３５６６％和２４２６％。１３８例用药前后的肝、肾功能检查均未见异常

The Urology Department of five hospitals including Jing’an District Central Hospital in Shanghai has clinically validated the effectiveness and safety of “Zhai Shu Capsule” in the treatment of benign prostatic hyperplasia of middle-aged and elderly men. 138 results were observed and treated: International Prostate Symptom Score (IPSS) The patients with significant improvements in the residual urine measurement and the maximum urinary flow rate (MFR) were 82 cases (138 cases in total), 46 cases (129 cases in total) and 33 cases (136 cases in total). The improvement rates were 59 cases. %, 3566% and 2426%. No abnormalities were found in liver and kidney function tests before and after treatment in 138 cases